Calcitonin
- 1 May 2003
- journal article
- review article
- Published by Elsevier in Clinics in Geriatric Medicine
- Vol. 19 (2) , 381-394
- https://doi.org/10.1016/s0749-0690(02)00070-8
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- A Randomized Trial of Nasal Spray Salmon Calcitonin in Men With Idiopathic Osteoporosis: Effects on Bone Mineral Density and Bone MarkersJournal of Bone and Mineral Research, 2002
- Comparison of Alendronate and Intranasal Calcitonin for Treatment of Osteoporosis in Postmenopausal WomenJournal of Clinical Endocrinology & Metabolism, 2000
- Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation.Journal of Clinical Investigation, 1995
- Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitoninJournal of Bone and Mineral Research, 1994
- A clinical trial on the effects of a combination of elcatonin (Carbocalcitonin) and conjugated estrogens on vertebral bone mass in early postmenopausal womenCalcified Tissue International, 1993
- Effect of salcatonin given intranasally on early postmenopausal bone loss.BMJ, 1989
- NASAL CALCITONIN FOR TREATMENT OF ESTABLISHED OSTEOPOROSISClinical Endocrinology, 1989
- Pain Killing with Calcitonin in Patients with Malignant TumoursOncology, 1986
- An evaluation of antibodies and clinical resistance to salmon calcitoninJournal of Clinical Investigation, 1972
- Calcitonin—a Hormone from the Parathyroid which Lowers the Calcium-level of the BloodNature, 1962